InvestorsHub Logo
icon url

vtem01

05/13/20 1:42 AM

#273213 RE: Whalatane #273197

Whala,

Kind of wonder, BO acquire those LCF as dollar per dollar saved. In this case it is over $2 per share. You mostly precise and that account for some calculation?
icon url

Meowza

05/13/20 9:08 AM

#273241 RE: Whalatane #273197

Ok, feel free :)
icon url

ilovetech

05/13/20 9:43 AM

#273252 RE: Whalatane #273197

Kiwi, Seriously?
____________________________________________________________________

Quote:

Oslo, Norway, 24 August 2012: Pronova BioPharma (OSE: PRON.OL) yesterday received notice that the Spanish Ministry of Health has decided, as part of a general measure to reduce healthcare expenditure, to discontinue reimbursement of Omacor with effect from 1 September. Pronova BioPharma and Grupo Ferrer, who holds the exclusive license to Omacor in Spain, object to the decision and are considering various actions to secure continued good access to Omacor for Spanish patients.
_________________________________________________________________

That's convenient. Where's the rest of their conclusions about the science? Upon further review, they likely found the effects "Unremarkable".

Following the landmark Reduce-it trial results, the EMA equivilent of our Medical Society of Cardiology, remmended the removal of Omacor from it's Stand of Care Guidance. They replaced the guidance with Icospant Ethyl 4g daily.


ILT



Following the release of the Reduce-it results, in 2019, the EMA equivilent of our Medical Society of Cardiology, recommeded Omacor removed from it's standard of Care guidelance, and list in it's place, Icosapent Ethyl as the new Standard of Care.